Loading organizations...
Loading organizations...
Biologic therapeutics based on Chemokine Analogue inhibitors.
Orion Biotechnology has raised $18.5M across 3 funding rounds.
Orion Biotechnology has raised $18.5M in total across 3 funding rounds.
Orion Biotechnology has raised $18.5M in total across 3 funding rounds.
Orion Biotechnology's investors include Howard Lubert, National Centre for Research and Development.
Orion Biotechnology has raised $18.5M across 3 funding rounds. Most recently, it raised $11.5M Series A in June 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 17, 2021 | $11.5M Series A | Howard Lubert | |
| Jul 17, 2018 | $2.0M Grant | National Centre for Research and Development | |
| Mar 20, 2018 | $5.0M Other Equity |